Why Sesen Bio Shares Are Skyrocketing Friday?

Sesen Bio Inc SESN shares are trading higher by 16.81% to $0.59 Friday morning after the company and Carisma Therapeutics announced an increased special dividend of $70 million, or $0.34 per share, in connection with the pending merger.

What Else?

Sesen Bio says the one-time special cash dividend expected to be paid to Sesen Bio stockholders will be increased to approximately $70 million, or approximately $0.34 per share, representing the amount of excess cash available after Sesen Bio meets a required net cash minimum of $75 million and represents an increase from the previously stated up to $25 million special cash dividend, or up to $0.12 per share.

Carisma's previously announced approximately $30 million financing remains committed and is expected to close concurrently with the merger.

See Also: US Stocks Stare At More Losses In Final Trading Session Of A Dismal Year — Analyst Sees Further Weakness Ahead

Dr. Thomas Cannell, President and Chief Executive Officer of Sesen Bio, said in a statement: "Since first announcing the merger, both companies have engaged extensively with Sesen Bio stockholders and continued to explore ways to deliver greater value in connection with the closing. The $45 million increase to the expected special cash dividend delivers even more direct and immediate cash value."

According to data from Benzinga Pro, Sesen Bio has a 52-week high of $0.96 and a 52-week low of $0.36.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!